Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients

Mark A. Applebaum, Aashish R. Jha, Clara Kao, Kyle M. Hernandez, Gillian DeWane, Helen R. Salwen, Alexandre Chlenski, Marija Dobratic, Christopher J. Mariani, Lucy A. Godley, Nanduri Prabhakar, Kevin White, Barbara E. Stranger, Susan L. Cohn

Research output: Contribution to journalArticle

Abstract

Neuroblastoma is notable for its broad spectrum of clinical behavior ranging from spontaneous regression to rapidly progressive disease. Hypoxia is well known to confer a more aggressive phenotype in neuroblastoma. We analyzed transcriptome data from diagnostic neuroblastoma tumors and hypoxic neuroblastoma cell lines to identify genes whose expression levels correlate with poor patient outcome and are involved in the hypoxia response. By integrating a diverse set of transcriptome datasets, including those from neuroblastoma patients and neuroblastoma derived cell lines, we identified nine genes (SLCO4A1, ENO1, HK2, PGK1, MTFP1, HILPDA, VKORC1, TPI1, and HIST1H1C) that are up-regulated in hypoxia and whose expression levels are correlated with poor patient outcome in three independent neuroblastoma cohorts. Analysis of 5-hydroxymethylcytosine and ENCODE data indicate that at least five of these nine genes have an increase in 5-hydroxymethylcytosine and a more open chromatin structure in hypoxia versus normoxia and are putative targets of hypoxia inducible factor (HIF) as they contain HIF binding sites in their regulatory regions. Four of these genes are key components of the glycolytic pathway and another three are directly involved in cellular metabolism. We experimentally validated our computational findings demonstrating that seven of the nine genes are significantly up-regulated in response to hypoxia in the four neuroblastoma cell lines tested. This compact and robustly validated group of genes, is associated with the hypoxia response in aggressive neuroblastoma and may represent a novel target for biomarker and therapeutic development.

Original languageEnglish (US)
Pages (from-to)76816-76826
Number of pages11
JournalOncotarget
Volume7
Issue number47
DOIs
StatePublished - 2016

Keywords

  • Hypoxia
  • Metabolism
  • Neuroblastoma
  • Pathway analysis
  • RNA expression

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients'. Together they form a unique fingerprint.

  • Cite this

    Applebaum, M. A., Jha, A. R., Kao, C., Hernandez, K. M., DeWane, G., Salwen, H. R., Chlenski, A., Dobratic, M., Mariani, C. J., Godley, L. A., Prabhakar, N., White, K., Stranger, B. E., & Cohn, S. L. (2016). Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients. Oncotarget, 7(47), 76816-76826. https://doi.org/10.18632/oncotarget.12713